Riskpilot← Back to searchSign inGet full accessBarkMed AB
ABActiveOrg 5568483217Enskedevägen 168 Lgh 1205General medical practice activities · NACE 8621Est. 20110 employees
Revenue 2025
SEK 100K
-70% vs 2024
EBITDA margin
86.4%
-69% vs 2024
Equity ratio
96.0%
Financial strength
Net profit 2025
SEK 74K
-69% vs 2024
| Revenue | SEK 100K | -70% |
| EBITDA | SEK 86K | -69% |
| Net profit | SEK 74K | -69% |
| Total assets | SEK 672K | -36% |
| Equity | SEK 645K | -34% |
| Employees | 0 | — |
Legal name
BarkMed AB
Org number
5568483217
Legal form
Aktiebolag
NACE code
8621 · General medical practice activities
Founded
2 april 2011
Share capital
SEK 50 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Företaget skall bedriva medicinsk konsultverksamhet och kapitalförvaltning.
Address
Enskedevägen 168 Lgh 1205
Email
sven_barkelius@hotmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 391 | 348 | 255 | 330 | 100 |
| Staff expenses | — | −0 | — | — | — |
| EBITDA | 309 | 262 | 165 | 279 | 86 |
| Depreciation & amort. | −0 | — | — | — | — |
| EBIT | 309 | 262 | 165 | 279 | 86 |
| Net financials | — | 0 | 3 | 26 | 7 |
| Profit before tax | 309 | 262 | 168 | 305 | 94 |
| Tax | −64 | −54 | −34 | −63 | −19 |
| Net profit | 245 | 208 | 134 | 242 | 74 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 1 227 | 1 407 | 1 037 | 1 058 | 672 |
| Equity | 1 136 | 1 345 | 978 | 971 | 645 |
| Long-term debt | 0 | — | — | — | — |
| Short-term debt | 91 | 62 | 59 | 87 | 27 |
| Total debt | 91 | 62 | 59 | 87 | 27 |
EBITDA margin
86.4%
This company
15.8%
Market median
+447% vs market
20212025
Equity ratio
96.0%
This company
38.2%
Market median
+151% vs market
20212025
Return on equity
11.5%
This company
18.4%
Market median
+37% vs market
20212025
Net profit margin
74.3%
This company
8.1%
Market median
+817% vs market
20212025
Asset turnover
0.15×
This company
1.12×
Market median
-87% vs market
20212025
Debt / equity
0.04×
This company
0.62×
Market median
+94% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Deputy Board Member | 2022 | |
| Board of Directors | 2022 | |
| Deputy Board Member | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of BarkMed AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Charlotte Anna Elisabeth Barkelius | Deputy Board Member | 0 companies |
| Sven Göran Barkelius | Board of Directors | 0 companies |
| Jenny Ellen Fredrika Barkelius | Deputy Board Member | 0 companies |